Physician

John Denesopolis, M.D.

According to 2025 Medicare claims, John Denesopolis, M.D. (NPI: 1518320092) practices vascular surgery in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is VASCULAR HEALTH LLC (NPI: 1053977801; TIN: 834407175) and primary practice location at 07728-2989. Denesopolis is affiliated with the HHC ACO Inc (ACO ID: A1675), participating under the MSSP model.

Denesopolis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 164 traditional Medicare patients, billed 15,376 HCPCS/CPT codes, and received $2,633,766 in Medicare payments. The top billing code was 37229 (Removal of plaque in artery of leg, initial vessel). Part D data shows 131 prescription claims across 58 beneficiaries totaling $28,454 in drug costs, led by Xarelto (Rivaroxaban). Open Payments data shows 7 records totaling $548. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,364 to $28,454. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.6M2024 Medicare payment: $2,633,766 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
202416415,376$2,633,766

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$14K$28K2016 Drug cost: $2,364 (USD; Tot_Drug_Cst)2017 Drug cost: $2,224 (USD; Tot_Drug_Cst)2018 Drug cost: $2,700 (USD; Tot_Drug_Cst)2019 Drug cost: $1,258 (USD; Tot_Drug_Cst)2020 Drug cost: $2,034 (USD; Tot_Drug_Cst)2021 Drug cost: $11,117 (USD; Tot_Drug_Cst)2022 Drug cost: $24,067 (USD; Tot_Drug_Cst)2023 Drug cost: $26,987 (USD; Tot_Drug_Cst)2024 Drug cost: $28,454 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20162156$2,364
20172564$2,224
2018N/R25$2,700
20191119$1,258
20201318$2,034
20211363$11,117
20222863$24,067
20232657$26,987
202458131$28,454

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
37229Removal of plaque in artery of leg, initial vessel101189$7,247
37252Ultrasound evaluation of blood vessel with review by radiologist, initial vessel113193$823
37253Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel112311$148
76937Ultrasonic guidance for blood vessel access121234$33
Q9967Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml9813,729$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XareltoRivaroxaban291,032$22,303
ClopidogrelClopidogrel Bisulfate381,740$219

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$548Smith+Nephew, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for John Denesopolis, M.D.?

Tedicare shows public-source Medicare data for John Denesopolis, M.D. (NPI 1518320092), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Denesopolis, M.D. have ACO affiliation data?

John Denesopolis, M.D. is shown with ACO affiliation data for HHC ACO Inc (MSSP, ACO ID A1675).

What billing organization is linked to John Denesopolis, M.D.?

John Denesopolis, M.D. is linked to VASCULAR HEALTH LLC (billing NPI 1053977801) in the available physician profile data.

Does John Denesopolis, M.D. have Open Payments data?

John Denesopolis, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.